Reblozyl (Luspatercept-Aamt) coverage
Customize your policy alerts
Sign up for sierra health and life Policy 2026D0084L alerts
Get alerted when Policy 2026D0084L changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity and authorization criteria for Reblozyl (luspatercept-aamt) for UnitedHealthcare Commercial and Individual Exchange benefit plans, covering specific hematologic indications in adults.
Template updated and content transferred to a shared policy template; Application section added specifying that the policy applies to UnitedHealthcare Commercial and Individual Exchange benefit plans.
Background, Clinical Evidence, and References sections updated to reflect the most current information.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.